Trium Capital’s Augmedix AUGX Stock Holding History
Bought
Maintained
Sold
Trium Capital's AUGX Position: Q4 2024 in Review
Trium Capital sold out of Augmedix (AUGX) in Q4 2024, closing a stake of 1,182,119 shares — an estimated $2.78M sold.
Trium Capital first reported a position in AUGX in Q3 2024 and held it in 1 quarter. The position peaked at $2.78M in Q3 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.
- Trium Capital reported no remaining Augmedix position as of Q4 2024 after selling out during the quarter.
- Trium Capital sold 1,182,119 Augmedix shares in Q4 2024, an estimated $2.78M.
- Trium Capital first reported a position in Augmedix in Q3 2024 and held it in 1 quarter.
- Trium Capital's Augmedix position peaked at $2.78M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Augmedix as of Q4 2024.
Based on Trium Capital's 13F filing for Q4 2024, filed 15 Jan 2025.